Amelioration of intestinal dysmotility and stasis by octreotide early after small-bowel autotransplantation in dogs by Nakada, K et al.
Amelioration of Intestinal Dysmotility 
and Stasis by Octreotide Early Mter 
Small-Bowel Autotransplantation in Dogs 
Koji Nakada, MD, Akira Ikoma, MD, Tomomi Suzuki, MD, James C. Reynolds, MD, 
William L. Campbell, MD, Satoru Todo, MD, Thoma'> E. Starzl, MD, PhD, Pittsburgh, Pennsylvania 
Reprinted from the March issue 
The American Journal of Surgery 
Excerpta Medica, Inc. 
a Reed Elsevier Medical Publishing company 
105 Raider Blvd., Belle Mead, NJ 08502 
Copyright 1995. All rights reserved. 
Printed in the U.S.A. 
SCIENTIFIC PAPERS 
Amelioration of Intestinal Dysmotility 
and Stasis by Octreotide Early Mter 
Small-Bowel Autotransplantation in Dogs 
Koji Nakada, MD, Akira Ikoma, MD, Tomomi Suzuki, MD, James C. Reynolds, MD, 
William L. Campbell, MD, Satoru Todo, MD, Thomas E. Starzl, MD, PhD, Pittsburgh, Pennsylvania 
BACKGROUND: Intestinal dysmotility and stasis af-
ter intestinal transplantation are considered to 
promote bacterial overgrowth and translocation. 
Two prokinetic agents, KW5139 (13-leu-motilin) 
and the somatostatin analogue octreotide acetate, 
were studied to determine whether they can ame-
liorate intestinal dysmotility during the early post-
operative period. 
MATERIALS AND METHODS: Motility was recorded by 
multiple extraluminal strain-gauge transducers in 6 
dogs on postoperative days 1, 3, 7, and 14. A 
barium meal study was performed with a separate 
group of 8 dogs on postoperative days 3 and 7. 
RESULTS: 'The agent KW5139 induced brief, 
weak contractions in the graft and had little effect 
on the dilated bowel; however, octreotide induced 
motor activity that propelled accumulated intesti-
nal contents into the colon and reduced dilation 
of the transplanted bowel. 
CONCLUSION: Octreotide, but not KW5139, ame-
liorates intestinal dysmotility associated with bowel 
autotransplantation during the early postoperative 
period. Short-term administration of octreotide 
may be useful for the treatment of dysmotility fol-
lowing intestinal transplantation. 
I t has been shown that motility of the intestinal graft is im-paired after small-bowel transplantation. I,2 Dysmotility 
during the early postoperative period is caused by muscular 
and nervous damage secondary to intestinal transection, den-
ervation, and ischemia. Dysmotility of the intestine causes 
stasis of the intestinal contents, leading to bacterial over-
growth,3,4 which leads to bacterial translocation and sepsis. 
Infectious complications are seen more frequently after in-
testinal transplantation5 than after transplantation of other 
solid organs. Therefore, amelioration of intestinal dysmotil-
ity and stasis during the early posttransplant period appears 
important to reduce the risk from these serious complications, 
Both motilin6 and somatostatin7-9 are known to induce 
phase 3 of the migrating motor complex. Phase 3 serves as 
a "housekeeper" of the intestine by propelling food residue, 
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secretions, and cell debris into the distal bowel,1O thereby 
preventing intestinal stasis. Dysmotility and intestinal stasis 
caused by disease!! or occurring after surgeryI2,13 have been 
shown to be ameliorated by motilin and somatostatin. In the 
present study, the effects of KW5139, a synthetic 13-leu-
motilin, and octreotide acetate, a somatostatin analogue, on 
impaired motility early after intestinal transplantation were 
studied in dogs using an autotransplantation model. 
Preliminary results were reported elsewhere. 14 
MATERIALS AND METHODS 
Animals 
Six adult mongrel dogs of both sexes weighing 18 to 25 
kg were used. They were given 1 g neomycin sulfate and 
500 mg metronidazole per day and fed with a low-residue 
diet for 5 days prior to surgery. Dogs were anesthetized with 
thiopental sodium (25 mglkg) for induction and maintained 
with halothane, nitrous oxide, and oxygen by positive-pres-
sure mechanical ventilation, Arterial blood pressure and 
electrocardiograms were monitored. 
Operative procedures 
Autotransplantation Procedure. Operative procedures 
of canine intestinal autotransplantation were reported previ-
ously.IS In brief, through a midline incision, the small in-
testine from the ligament of Treitz to approximately 10 cm 
from the ileocecal valve was isolated on a vascular pedicle 
of the superior mesenteric artery and vein. After removing 
the intestine, the graft was perfused via the superior mesen-
teric artery with I L cold lactated Ringer's solution con-
taining 2,000 U heparin sodium and 0.3 mg kanamycin sul-
fate at 150 mm Hg. The intestinal lumen was irrigated with 
1 L of the same solution. After perfusion, the graft was im-
mediately reimplanted into the same dog. The donor and na-
tive superior mesenteric artery and vein were anastomosed 
in end-to-end fashion. Intestinal continuity was restored by 
end-to-end anastomosis of the jejunum and ileum, 
Strain Gauge Transducer Placement. Eight strain gauge 
transducers (Star Medical Co., Tokyo, Japan) were implanted 
before wound closure at the gastric antrum (5 cm proximal 
to the pylorus), the pylorus, the duodenum (5 cm distal to the 
pylorus), the graft jejunum (15 cm and 45 cm distal to the 
duodenojejunal anastomosis), the graft ileum (40 cm and 10 
cm proximal to the ileoileal anastomosis), and the host ileum 
(3 to 5 cm distal to the ileoilea1 anastomosis). Strain gauge 
transducer lead wires were tunneled subcutaneously and 
brought out between the scapulae. A protective jacket (Star 
Medical Co.) was placed on each dog to protect the lead wires. 
Postoperative Management 
Animals received 1 L 5% dextrose in O.2N sodium chlo-
ride every 24 hours for 3 days postoperatively. One gram 
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Barium studies were perfom1ed 
on a second group of 8 autotrans-
planted dogs on postoperative days 
3 and 7. Fifty milliliters of 45% 
wtlvol barium sulfate suspension 
without any nutrients was intro-
duced through an orogastric tube, 
followed 30 minutes later by a O.l-
I-Lg/kg intravenous bolus of 
KW5139, and 60 minutes after that 
by a 0.25-I-Lg/kg octreotide acetate 
intravenous bolus. The fluoro-
scopic images were observed on a 
television monitor and stored on 
videotape. Posteroanterior radio-
graphs were obtained before and 
15 and 30 minutes after introduc-
ing the barium meal, and at 5, 15, 
and 30 minutes after administra-
tion of each drug. 
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Figure 1. Postoperative changes in interdigestive motility after smal~bowel autotransplantation in 
the same dog: A. postoperative day 1; B. postoperative day 3; C. postoperative day 7; and D. 
postoperative day 14. Incidence and duration of bursts of contractions (BOC) increased with time. 
A dot signifies spontaneous phase 3 in the graft and an arrow indicates propagation of phase 3. 
of cefamandol nafate was given intramuscularly during 
surgery and then daily for 5 days. Dogs were allowed to 
drink and eat from the day after surgery. A meat-based, 
low-residue liquid meal was given for the first 3 days af-
ter surgery, followed by a low-residue, solid-meat meal un-
til postoperative day 7. Animals were fed standard kennel 
food thereafter. 
Motility Recordings 
Intestinal motility was recorded in fully conscious dogs 
on postoperative days l, 3, 7, and 14. Food was withdrawn 
for 18 hours before each measurement. An orogastric tube 
was gently inserted to the stomach 6 to 8 hours prior to 
each recording period, and if any residual food was pre-
Data Analysis 
The recorded motility of transplanted jejunoileum was vi-
sually analyzed. Phasic contractions lasting for a minimum 
of 30 seconds with an amplitude of greater than 30 g and a 
frequency of greater than 10 min- i were defmed as BOCs. 
Spontaneous, strong, repetitive phasic contractions lasting 
for more than 4 minutes and propagating aborally were de-
fined as phase 3 contractions. Drug-induced strong, repeti-
tive phasic contractions lasting for longer than 2 minutes 
were defined as phase-3-like contractions. The total dura-
tion of spontaneous contraction bursts (the sum of the du-
ration of each burst), and the maximum duration and max-
imum amplitude of spontaneous contractions from the last 
3 hours of the baseline recording were compared with the 
THE AMERICAN JOURNAL OF SURGERY® VOLUME 169 MARCH 1995 295 
INTESTINAL DYSMOTlLlTY AFTER SMALL-BOWEL AUTOTRANSPLANTIONINAKADA ET AL 
A B 
t t 
60 60 (min/3h) (minl3h) 
U U 
0 0 
III 40 m 40 
'0 '0 
II: II: 
0 0 
;:I = I! 20 I! 20 
:::l :::J 
C Q 
i J t- O 0 
POD 1 POD 3 POD 7 POD 14 POD 1 POD 3 POD 7 POD 14 
C 0 
t 
() u (9) t 0 (g) 0 
m ID 
'0 200 '0 200 
III • 
'1:1 '1:1 
:::J 
.a ~ a 
-a 
E 100 E 100 ~ ~ 
E E 
:::J :::J 
E E 
-;c -;c 
• • :::e 0 :::& 0 
POD 1 POD3 POD 7 POD 14 POD 1 POD 3 POD7 POD 14 
Figure 2. Changes in total duration and maximum amplitude of bursts of contractions (BOC) after small-bowel transplantation: A. total duration 
(jejunum); B. total duration (ileum); C. maximum amplitude (jejunum); and D. maximum amplitude (ileum). Total duration and maximum amplitude 
of BOC significantly increased with time .• P <0.05 versus postoperative day 1. tP <0.05 versus postoperative day 3. 
motility recordings after drug administration. The mean of 
the five highest amplitudes of contraction bursts was de-
fined as the amplitude of BOCs. 
The incidence of phase 3 contractions was analyzed dur-
ing the entire baseline recording period. The type of oc-
treotide-induced phase-3-like contractions was analyzed ac-
cording to the criteria described by Peeters et al,16 who 
defined phase-3-like contractions seen either in jejunal or 
ileal sites as "isolated" contractions, those propagating from 
jejunum to ileum as "propagated" contractions, and those 
observed simultaneously in both the jejunum and the ileum 
as "simultaneous" contractions. The maximum diameter of 
the bowel graft was measured in radiographs before and 30 
minutes after octreotide injection. 
Statistical analysis was performed using the Wilcoxon's 
rank sum test. 
RESULTS 
All dogs survived the autotransplantation procedure. The 
dogs were healthy throughout the study period, and had a 
good appetite. They lost 10.7% ± 1.3% of their weight dur-
ing the first 2 weeks of the study. Watery diarrhea devel-
oped 3 days after bowel transplantation and persisted 
throughout the experimental period. 
Motility Recordings 
Motility of the intestinal grafts was greatly inhibited for 
the first 3 days after autotransplantation (Figure 1). The 
baseline recordings at postoperative day I (Figure lA) and 
day 3 (Figure lB) showed long periods of quiescence, which 
TABLE 
Appearance and Incidence of Phase 3 Activity 
in the Transplanted Bowel 
Appearance (nIN), Incidence (n/hlt 
POD Jejunum Ileum Jejunum Ileum 
1 4/6 2/6 0.13±0.05l § 0.17±0.W 
3 5/6 5/6 0.44 ± 0.l6 0.23 ± 0.07 
7 6/6 5/6 0.73 ± 0.05 0.52 ± 0.13 
14 6/6 5/6 0.70 ± 0.13 0.36 ± 0.l0 
'Number of dogs activity with phase 3 per number of experiments. 
tNumber of phase 3 contractions per hour. 
lP<O.05 compared with POD 7. 
§P<O.05 compared with POD 14. 
POD; postoperative day. 
was occasionally interrupted by irregular weak and short 
contractions. Total duration and maximum amplitude of 
BOCs were significantly less in the jejunum and ileum dur-
ing this early period (Figure 2). After postoperative day 7, 
however, intense and longer phasic contractions appeared 
in the intestine, and contractile activity became much more 
evident (Figures Ie and D). Phase 3 activity was absent or 
occurred rarely in this early postoperative period (Table). 
The agent KW5139 always induced strong, repetitive pha-
sic contractions in the gastroduodenum from postoperative 
day 1, but the contractions occurring in the graft were brief 
and very irregular (Figure 3). No phase-3-like contractions 
developed in the graft after KW5139 administration. Phase-
3-like contractions occurring in the native stomach and duo-
denum did not propagate into the graft beyond the proximal 
intestinal anastomosis. 
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Octreotide always induced intense phase-3-like contrac-
tions in the intestinal graft within 5 minutes after drug in-
jection (Figure 3). Induction of these contractions was seen 
on postoperative day 1, when motility was markedly im-
paired. Simultaneous contractions (17 of 21) were predom-
inant and occurred more often than isolated (4 of 21) or 
propagated (0 of 21) contractions. In contrast to KW5139, 
octreotide rarely produced phase-3-like contractions in the 
host stomach (0 of 21) or duodenum (5 of 21). 
The duration and amplitude of KW5139-induced contrac-
tions were insignificant when compared with those of spon-
taneous BOCs (P <0.05), whereas octreotide-induced con-
tractions were similar to those of the spontaneous bursts. 
Radiologic Study 
On postoperative day 3 (Figure 4A), the transplanted small 
bowel and the host gastroduodenum were hypoperistaltic 
and dilated when compared with radiological findings on 
postoperative day 7 (Figure 4B). When KW5139 was given, 
strong peristaltic contractions, lasting less than 10 minutes, 
occurred at the host stomach and duodenum, and emptied 
the contrast material into the small bowel. However, 
KW5139 had little effect on the dilated small bowel; only 
weak and insignificant contractions were seen. In contrast, 
octreotide induced strong and repetitive peristalsis through-
out the entire intestine. However, this effect was not seen 
in the stomach. Fifteen minutes after octreotide injection, 
contrast material was propelled to the distal bowel, and the 
graft had cleared almost all the contrast material into the 
colon (Figure 4C). The maximum diameter of the dilated 
small-bowel graft was 14.8 ± l.5 mm before octreotide in-
jection, and was significantly reduced to 6.8 ± l.5 mm 30 
minutes after octreotide injection (P <0.05). 
COMMENTS 
In the present study, the effects of KW5139 and octreotide 
on dysmotility and stasis of the intestinal graft during the 
early period after transplantation were studied in dogs. An 
autotransplantation method was used in the experiment to 
eliminate the influence of rejection and immunosuppressive 
agents 17 on intestinal motility. We found that motility of the 
intestinal grafts was severely impaired 3 days after trans-
plantation and recovered after 7 days. Impairment of motil-
ity during the immediate postoperative period was charac-
terized by very little contractile activity and by intestinal 
stasis. The agent KW5139 induced strong contractions in 
the gastroduodenum but had little effect on a dilated small 
bowel. On the other hand, octreotide caused strong phase-
3-like contractions in the jejunoileal graft even on postop-
erative day I, when motility was most abnormal. Vigorous 
peristalsis occurred in the graft, and the accumulated in-
testinal contents were emptied into the colon. Intestinal sta-
sis was virtually corrected by treatment with octreotide. 
In the fasting motor activity of a normal subject, the mi-
grating motor complex is classified into four separate phases 
that propagate from the proximal gastrointestinal tract to the 
distal intestine. Of the four phases,18 phase 3 is considered 
to have a distinctive role in the movement of intestinal con-
tents by intense phasic contractions, or peristalsis, along the 
entire intestinal tract. After abdominal surgery, disappear-
ance of phase 3 contractions and resulting intestinal stasis 
have been observed.12•19 The duration of the disappearance 
correlated with the severity of operative insults. After in-
testinal transplantation, reappearance of these contractions 
was greatly delayed. In rats, they reappeared after 11 days? 
whereas it took 2 to 6 weeks in dogs.2o In the present study, 
however, we found phase 3 contractions in the grafts, though 
very rare, even on postoperative day 1 after autotransplan-
tation. Differences in species and monitoring methods may 
have caused these disparities. 
Although both KW5139 and octreotide induce phase-3-
like contractions in the normal intestine, I 1-13 each drug's in-
fluence on the transplanted intestine was quite different. 
Whereas KW5139 showed little effect on contractile activ-
ity of the graft, octreotide induced vigorous contractions; 
and KW5139 caused contractions in the gastroduodenum 
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Figure 4. Radiological findings on days 3 and 7 following bowel trans-
plantation and effect of octreotide-induced motor activity on propu~ 
sion of intestinal contents on postoperative day 3. A. On postopera-
tive day 3, the transplanted jejunoileum was markedly dilated. B. On 
postoperative day 7, dilation of the graft was reduced. C. On post-
operative day 3, 15 minutes after octreotide injection, octreotide-in-
duced motor activity propelled contrast material to the colon. The 
graft bowel was emptied by this motility effect, which was accompa-
nied by a reduction in the dilation of the bowel. 
but octreotide did not. It appears that KWSl39 and oc-
treotide exert their motor effects via different mechanisms. 
It has been shown that atropine abolishes the prokinetic ef-
fect of these agents in the normal intestine,8.21 indicating that 
cholinergic neurons are involved. There are two cholinergic 
pathways in the gastrointestinal tract-Dne is via the ex-
trinsic nervous system and the other is via the intrinsic ner-
vous system. When hexamethonium is given22 or the intes-
tine is neurally isolated by denervation and transection,23 
induction of phase-3-like activity by motilin, the mother 
drug of KWS139, is lost. Therefore, KWSl39 appears to in-
duce phase-3-like contractions in the intestine through the 
extrinsic nerve. In a segmental intra-arterial perfusion ex-
periment , Hostein et al9 demonstrated that somatostatin, the 
mother drug of octreotide, induced contractile activity just 
distal to the perfused segment, whereas systemic intravenous 
administration caused no changes. Octreotide is thought to 
induce motor activity in the intestine via a local mechanism. 
The absence of a prokinetic effect on the stomach by so-
matostatin2-1 has been reported . 
In the transplanted intestine, most of the phase-3-like con-
tractions induced by octreotide developed simultaneously, 
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using the same dose that induced propagated contractions 
in the normal intestine.16 Since the extrinsic nerve has been 
shown to modulate initiation or propagation, or both, of 
phase 3 contractions in the small boweJ,25 denervation may 
have influenced the pattern of phase-3-like contractions in 
the intestinal grafts. 
To our knowledge, no radiological studies have previ-
ously been performed to study the effect of prokinetic 
agents on intestinal dysr~otility following bowel trans-
plantation. By the third day after transplantation, intesti-
nal peristalsis was weak and hardly seen. The intestine was 
markedly dilated, showing severe intestinal stasis. 
Octreotide, but not KW5139, ameliorated this stasis, pos-
sibly by drug-induced phase-3-like contractions. In normal 
dogs, the occurrence of peristalsis and the elimination of 
contrast material were shown to coincide with the appear-
ance of phase 3 contractions.3 
When intestinal stasis persists, it becomes a source of many 
clinical problems. Intestinal stasis not only causes bacterial 
overgrowth and translocation, but also fluid and electrolyte 
imbalance and microcirculatory disturbance of the intesti-
nal wall, and may prolong recovery of patients after trans-
plantation. Therefore, it appears important to treat intestinal 
stasis to reduce these risks, esPecially during the immediate 
postoperative period when the graft :suffers the most severe 
dysmotility caused by damage from preservation and 
surgery. Of the two agents studied in the present experiment, 
only octreotide demonstrated amelioration of intestinal sta-
sis. In addition to its prokinetic effect, octreotide, or so-
matostatin, has other benefits: it inhibits gastric, pancreatic, 
and biliary secretions,26 which may reduce intractable diar-
rhea (another major problem after intestinal transplanta-
tion),27 and it attenuates ischemic intestinal injury by sup-
pressing trypsin activity in the intestinal contents.28 
However, somatostatin also has deleterious effects, such as 
gallstone formation,29 the inhibition of enterocyte prolifera-
tion,30 and nutrient absorption.26 These effects may be 
avoided by limiting its use to a brief postoperative period. 
Clinical evaluation of the use of octreotide in intestinal trans-
plant recipients is currently under investigation. 
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